TNF-Alpha Inhibition for Treatment of Alzheimer's Disease - Contacts and Locations

Home

TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

This study has been completed.

Study NCT00203359. Last updated on April 20, 2006. Information provided by Tobinick, Edward Lewis, M.D.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00203359

Locations


United States, California
	Edward Tobinick, MD (private medical office)
	Los Angeles, California, United States, 90095

Sponsors and Collaborators

Tobinick, Edward Lewis, M.D.

Investigators


Principal Investigator:	Edward L Tobinick, MD	unaffiliated (Assistant Clinical Professor of Medicine, David Geffen School of Medicine at UCLA)